The Association’s output based on the expertise of its members and of participating non-members is maximized through the operation of Working Groups.
The Working Groups will cover:
1. A Newsletter
2. Viral Hepatitis as a Millennium Development Goal.
3. Barriers to treatment and care for patients with hepatitis B and C in the EU
The first issue of the Association’s quarterly Newsletter was published in March 2012 (view Newsletter). Succeeding issues continue to summarize briefly the most recent data on epidemiology, prevention, public policy and therapeutic and diagnostic improvements for hepatitis B and C. The Newsletter is aimed at national and multi-lateral health authorities and regulators, advocacies including patients’ associations, and the general media as well as general practitioners and hepatologists.
Massimo Colombo, Co-Chair of the Hepatitis B and C Public Policy Association, leads the Newsletter’s editorial team and Editorial Board of leading international experts in viral hepatitis research.
For any comments on this project please contact Prof. Colombo directly on firstname.lastname@example.org.
2) Global Hepatitis Partnership
The Association’s Working Group on Hepatitis as a Millenium Development Goal hosted a high-level meeting of international policy experts in London in December 2011, which agreed an approach towards highlighting viral hepatitis as a global public health emergency.
The Association is now exploring with the International Association of National Public Health Institutes (IANPHI) and the World Federation of Public Health Associations how set up such a partnership. It would complement the very new global hepatitis network being set up by the World Health Organisation.
The Working Group is led by Charles Gore, Co-Chair of the Hepatitis B and C Public Policy Association and by Howard Thomas, founder member of the Association.
3) Barriers to Treatment & Care
The Association has commissioned an investigation into the subject of barriers to care and treatment for patients with chronic viral hepatitis in the EU.
Principal investigators Prof. George Papatheodoridis and Prof. Heiner Wedemeyer, both members of the Association, are have produced 2 pieces of work:
- A systematic review and evaluation on barriers to care and treatment for patients with chronic viral hepatitis in europe and
- Perceptions on barriers to the appropriate management for patients with chronic viral hepatitis in EU Member States
For any comments on this project please contact Prof. Papatheodoridis on email@example.com.